Remove 2030 Remove Communication Remove Compounding
article thumbnail

Healthier Together and philanthropic ventures in tropical disease

European Pharmaceutical Review

The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. Europe’s Healthier Together initiative. A guidance document has been released to support these activities.

Vaccines 110
article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

Their projections indicate that approximately 10,000 people will turn 65 each day over the next 19 years, with the population of older adults expected to double to 80 million by 2030. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. Data from the U.S. in 1994 to 42.4%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacy united in the recovery of healthcare

Hospital Pharmacy Europe

Worldwide, more than 700,000 people die by suicide annually and the WHO has set a target to reduce suicides by one third by 2030. was a remarkably effective way to establish good communication, he said. In England and Wales, there were 10.7 Without some proficiency in health literacy, it is difficult to undertake effective self-care.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Nature Communications 12, no. 3 , 27 Advantages POD increases manufacturing flexibility, speed, and consistency. 3 (2020):e2970.

article thumbnail

PharmaShots' Key Highlights of First Quarter 2023

PharmaShots

It now offers DPN patients relief from chronic pain through low doses of stimulation & the battery lasts up to 10 years at low-dose settings The system also pairs with Abbott’s NeuroSphere Virtual Clinic, a connected care app for people to communicate with a physician and receive remote treatment adjustments.

FDA 40
article thumbnail

Challenges for Net Zero Carbon Pharmaceutical Manufacturing

ISPE

C global warming scenario by 2030, which is widely acknowledged to be necessary to avoid the worst impacts of climate change. You may unsubscribe from these ISPE communications at any time. This study showed that only 9% of the companies currently have targets aligned with a 1.5°C C global warming scenario. Leave this field blank

article thumbnail

Readmission on the Horizon: How EU funding can boost British biotech

Pharmaceutical Technology

The possibility of additional funding comes at a time replete with investor uncertainty as a result of ongoing financial instability in the market, which has been compounded by the collapse of Silicon Valley Bank (SVB) and Credit Suisse. billion) by 2030. The UK government also has its own plans for funding research. billion ($18.2

Vaccines 111